GENMAB A/S: Financial statements 2014
CVR: 21023884
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
GENMAB A/S (CVR 21023884) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 850,385,000 and a net result of DKK 301,296,000. The profit margin was 35.4%. Equity in the 2014 report amounted to DKK 2,032,939,000. The solvency ratio was 70.9%.
- Revenue
- DKK 850,385,000
- Profit/Loss
- DKK 301,296,000
- Equity
- DKK 2,032,939,000
- Total Assets
- DKK 2,866,681,000
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
GENMAB A/S has published its interim report for the period July 1, 2014 – September 30, 2014.
As of September 30, 2014, Anders Boelskift has left the board of directors of GENMAB A/S.
GENMAB A/S has published its interim report for the period January 1, 2014 – June 30, 2014.
GENMAB A/S has published its interim report for the period January 1, 2014 – March 31, 2014.
GENMAB A/S has published its annual report for 2013.
About GENMAB A/S
GENMAB A/S is a Danish company of the type Aktieselskab based in Valby, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named GFKJUS 519 ApS. The management consists of Jan van de Winkel and Anthony Michael Pagano. The board consists of Deirdre Patrice Connelly (chair), Pernille Lyngvold Erenbjerg, Anders Gersel Pedersen and Elizabeth Grimes O’Farrell. The company is owned by BLACKROCK, INC.. The company has 676 employees (2026). In 2025, the company reported revenue of USD 3,720,000,000 and a net result of USD 963,000,000 compared with DKK 7,844,000,000 the year before. Equity in the 2025 report amounted to USD 5,847,000,000.